Correlation Between ZyVersa Therapeutics and Qualigen Therapeutics
Can any of the company-specific risk be diversified away by investing in both ZyVersa Therapeutics and Qualigen Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ZyVersa Therapeutics and Qualigen Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between ZyVersa Therapeutics and Qualigen Therapeutics, you can compare the effects of market volatilities on ZyVersa Therapeutics and Qualigen Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ZyVersa Therapeutics with a short position of Qualigen Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of ZyVersa Therapeutics and Qualigen Therapeutics.
Diversification Opportunities for ZyVersa Therapeutics and Qualigen Therapeutics
0.88 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between ZyVersa and Qualigen is 0.88. Overlapping area represents the amount of risk that can be diversified away by holding ZyVersa Therapeutics and Qualigen Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Qualigen Therapeutics and ZyVersa Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ZyVersa Therapeutics are associated (or correlated) with Qualigen Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Qualigen Therapeutics has no effect on the direction of ZyVersa Therapeutics i.e., ZyVersa Therapeutics and Qualigen Therapeutics go up and down completely randomly.
Pair Corralation between ZyVersa Therapeutics and Qualigen Therapeutics
Given the investment horizon of 90 days ZyVersa Therapeutics is expected to under-perform the Qualigen Therapeutics. In addition to that, ZyVersa Therapeutics is 1.01 times more volatile than Qualigen Therapeutics. It trades about -0.09 of its total potential returns per unit of risk. Qualigen Therapeutics is currently generating about -0.04 per unit of volatility. If you would invest 3,800 in Qualigen Therapeutics on August 25, 2024 and sell it today you would lose (3,317) from holding Qualigen Therapeutics or give up 87.29% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Strong |
| Accuracy | 100.0% |
| Values | Daily Returns |
ZyVersa Therapeutics vs. Qualigen Therapeutics
Performance |
| Timeline |
| ZyVersa Therapeutics |
| Qualigen Therapeutics |
ZyVersa Therapeutics and Qualigen Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with ZyVersa Therapeutics and Qualigen Therapeutics
The main advantage of trading using opposite ZyVersa Therapeutics and Qualigen Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ZyVersa Therapeutics position performs unexpectedly, Qualigen Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Qualigen Therapeutics will offset losses from the drop in Qualigen Therapeutics' long position.| ZyVersa Therapeutics vs. Cns Pharmaceuticals | ZyVersa Therapeutics vs. Immix Biopharma | ZyVersa Therapeutics vs. Hepion Pharmaceuticals | ZyVersa Therapeutics vs. Zura Bio Limited |
| Qualigen Therapeutics vs. ZyVersa Therapeutics | Qualigen Therapeutics vs. Immix Biopharma | Qualigen Therapeutics vs. Phio Pharmaceuticals Corp | Qualigen Therapeutics vs. 180 Life Sciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.
Other Complementary Tools
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios |